Show simple item record

dc.contributor.advisorApte, Udayan
dc.contributor.authorMcGreal, Steven
dc.date.accessioned2018-10-25T16:12:23Z
dc.date.available2018-10-25T16:12:23Z
dc.date.issued2017-12-31
dc.date.submitted2017
dc.identifier.otherhttp://dissertations.umi.com/ku:15645
dc.identifier.urihttp://hdl.handle.net/1808/27029
dc.description.abstractO-GlcNAcylation is a covalent attachment of a single N-acetyl glucosamine to a serine or threonine residue of a protein. Unlike other forms of protein glycosylation, there is no chain elongation in O-GlcNAcylation. O-GlcNAc transferase (OGT) adds O-GlcNAcase (OGA) removes O-GlcNAc from a protein. The process of O-GlcNAcylation is dynamic and has extensive crosstalk with protein phosphorylation. O-GlcNAcylation plays an important role in cell cycle progression, metabolic disorders, cancer, and responses to various stressors. The role of O-GlcNAc in liver injury and regeneration has not been clearly defined. Due to the wide array of cellular processes and pathologies that involve O-GlcNAc and the knowledge gap in liver injury and regeneration, we set out to determine the role O-GlcNAc plays in liver injury and regeneration. APAP is the most widely used over-the-counter analgesic and antipyretic in the western world. Overdose of APAP leads to GSH depletion and centrilobular liver damage. First, we looked at the role of O-GlcNAc in response to APAP overdose in mice using both a decrease and an increase in O-GlcNAcylation. Hepatocyte specific deletion of OGT (OGT KO) in mice was used to decrease O-GlcNAcylation. OGT KO mice and WT mice were treated with 300 mg/kg APAP and the development of liver injury was studied over a time course of 0-24 hr. OGT KO mice showed dramatic decrease in liver injury compared to wild type mice. Serum ALT levels were markedly decreased in all timepoints in OGT KO mice and immunohistochemistry showed no centrilobular necrosis or cell death. OGT KO mice showed decrease in APAP-Cys protein adducts. There was no difference in CYP2E1 protein levels or activity and initial GSH depletion between OGT KO and WT mice. There was rapid replenishment of GSH in OGT KO mice and induction of enzyme critical to GSH biosynthesis and recycling. Treatment with Thiamet-G (TMG), a potent inhibitor of OGA, was used to model a increase in O-GlcNAcylation. C57BL/6J mice were treated acutely with 400 mg/kg TMG 1.5 hr after APAP treatment. TMG treated mice showed an increase in APAP-induced liver injury as seen by Serum ALT immunohistochemistry. Acute TMG treatment also induced a prolonged JNK activation. Treatment with acute TMG did not affect hepatic CYP2E1 levels, APAP-protein adducts, and APAP-induced mitochondrial damage. Whereas GSH depletion was not different, GSH replenishment and GSH biosynthesis genes were lower in TMG-treated mice after APAP overdose. Next, we examined the effects of OGT KO on liver regeneration after partial hepatectomy (PHX). WT mice had normal regeneration that subsided at 7 days post PHX. OGT KO mice showed normal regeneration up to 48 hr post PHX, but exhibited significant increase in liver regeneration from 5-14 days post PHX. OGT KO mice had higher liver to body weight ratio at 7 and 14 days and several pathways known to be critical in liver regeneration remained active out to 14 days post PHX. Indicative of an increase in proliferation, protein associated with cell cycle and cell cycle progression such as Cyclin D1, A2, B1, pRb, and CDK4 levels were all elevated at later time points. HNFα was decreased at 14 days, and several genes knows to be down regulated by HNF4a had increased fold change as seen in RNA-Seq data. Taken together, this data shows that OGT KO increases liver regeneration after PHX and leads to a loss of termination of liver regeneration. Overall, these studies show that O-GlcNAcylation plays a central role in liver injury and regeneration, and could potential lead to therapeutic interventions for APAP induce acute liver failure and liver cancer.
dc.format.extent113 pages
dc.language.isoen
dc.publisherUniversity of Kansas
dc.rightsCopyright held by the author.
dc.subjectToxicology
dc.subjectAcetaminophen
dc.subjectLiver
dc.subjectO-GlcNAc
dc.subjectregeneration
dc.titleThe Role of O-GlcNAc in Liver Injury and Regeneration
dc.typeDissertation
dc.contributor.cmtememberJaeschke, Hartmut
dc.contributor.cmtememberSlawson, Chad
dc.contributor.cmtememberKasturi, Partha
dc.contributor.cmtememberLi, Tiangang
dc.thesis.degreeDisciplinePharmacology, Toxicology & Therapeutics
dc.thesis.degreeLevelPh.D.
dc.identifier.orcid
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record